United Kingdom· GB-APID-4087411000001100
Minims proxymetacaine 0.5% eye drops 0.5ml unit dose
A proxymetacaine product containing proxymetacaine, registered in United Kingdom by Bausch & Lomb UK Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Proxymetacaine is registered in 10 of 19 countries.
Countries holding a registration under ATC S01HA04 (proxymetacaine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Proxymetacaine · ATC S01HA04
10 / 19 countries
- Belgiumprice
- Canada
- Germany
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Proxymetacaine
- Manufacturer
- Bausch & Lomb UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- S01HA04
- ATC class
- Proxymetacaine
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5027519005604
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for proxymetacaine.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Proxymetacaine · interactions on record
20 records
- 20 moderate
Most severe, free to view
- MetoclopramideA03FA01moderate
- SulfamethizoleB05CA04moderate
- LidocaineC01BB01moderate
- Silver sulfadiazineD06BA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Proxymetacaine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAlcaineAlcon Laboratories, Inc.
- PolandAlcaineInPharm Sp. z o.o.
- NorwayAlcaineAlcon Nordic A/S
- GermanyProparakain-PosUrsapharm Arzneimittel Gmbh
- BelgiumAlcaine 0.5 %Alcon
- IcelandAlcaineAlcon Nordic A/S
- IrelandMinims Proxymetacaine hydrochloride 0.5% w/v, Eye Drops, SolutionBausch + Lomb Ireland Limited
- CanadaALCAINEALCON CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Alcaine
- Bulgaria · Алкаин
- Cyprus · Alcaine
- Germany · Proparakain-Pos
- Greece · Alcaine
- Ireland · Minims
- Iceland · Alcaine
- Lithuania · Alcaine
- Norway · Alcaine
- Poland · Alcaine
- Slovenia · Alcaine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55d3eb54-3921-4e1a-b169-f8e9e2baa617 GET /v1/drugs/55d3eb54-3921-4e1a-b169-f8e9e2baa617?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4087411000001100",
"desc": "Minims proxymetacaine 0.5% eye drops 0.5ml unit dose (Bausch & Lomb UK Ltd)",
"form": "Eye drops",
"vpid": "4090611000001102",
"source": "dmd",
"vtm_id": "777355007",
"strength": "5 mg",
"substance": "Proxymetacaine",
"ingredient": "Proxymetacaine hydrochloride",
"supplier_code": "3022501000001105"
}See everything about proxymetacaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.